openPR Logo
Press release

Exploring the Expanding Intravenous Immunoglobulin (IVIG) Market: Understanding the Growing Demand for Immunoglobulin Therapy in Treating Autoimmune and Neurological Disorders

04-18-2023 04:11 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Exploring the Expanding Intravenous Immunoglobulin (IVIG)

Intravenous Immunoglobulin, also known as IVIG, is a medication made up of proteins called immunoglobulins that are extracted from the blood of many different donors. These immunoglobulins are used to treat various medical conditions that affect the immune system, such as autoimmune diseases or infections.

๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ข๐ง๐ญ๐ซ๐š๐ฏ๐ž๐ง๐จ๐ฎ๐ฌ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐œ๐œ๐จ๐ฎ๐ง๐ญ๐ž๐ ๐Ÿ๐จ๐ซ $๐Ÿ–,๐Ÿ—๐Ÿ—๐Ÿ“ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•, ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก $๐Ÿ๐Ÿ“,๐Ÿ—๐Ÿ”๐Ÿ’ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“, ๐ซ๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ๐ข๐ง๐  ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ•.๐Ÿ“% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ– ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

https://www.alliedmarketresearch.com/request-sample/325

The global IVIG market is driven by factors such as high prevalence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia coupled with surge in geriatric population and rise in the number of hemophilic patients. In addition, increase in production of immunoglobulin with better plasma quality using advanced purification techniques is expected to supplement the market growth. On the other hand, technological advancements in IVIG products are anticipated to provide lucrative opportunities in the market in near future. However, stringent government regulations towards IVIG products and side effects associated with the use of IVIG impede the growth of the market.

When someone receives IVIG, the immunoglobulins are given through a vein in the arm and are infused into the bloodstream. Once in the bloodstream, the immunoglobulins work to boost the immune system's ability to fight off infections and diseases by providing additional antibodies to the body.

IVIG is often used as a treatment option when other medications have not been effective, and it can help reduce the severity and duration of certain illnesses. The medication is generally considered safe, but like any medication, there can be side effects. It is important to discuss the potential benefits and risks with a healthcare provider before starting treatment.

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ฐ๐ก๐ž๐ซ๐ž ๐ˆ๐•๐ˆ๐† ๐ข๐ฌ ๐ฎ๐ฌ๐ž๐ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž:

Autoimmune diseases: IVIG is used to treat autoimmune diseases such as lupus, rheumatoid arthritis, and multiple sclerosis.

Immunodeficiencies: IVIG is used to treat primary immunodeficiency disorders (PIDs) and secondary immunodeficiencies, which can occur as a result of certain medical treatments, such as chemotherapy.

Neurological disorders: IVIG is used to treat neurological disorders such as Guillain-Barrรฉ syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis.

Blood disorders: IVIG is used to treat blood disorders such as idiopathic thrombocytopenic purpura (ITP) and Kawasaki disease.

Infectious diseases: IVIG is used to treat certain infectious diseases such as HIV and hepatitis B.

The specific segment of IVIG use depends on the patient's medical condition and the doctor's recommendation.

๐€๐ฌ๐ค ๐ญ๐จ ๐Ž๐ฎ๐ซ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ:

https://www.alliedmarketresearch.com/purchase-enquiry/325

๐“๐ก๐ž ๐ญ๐จ๐ฉ ๐Ÿ๐ŸŽ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ˆ๐ง๐ญ๐ซ๐š๐ฏ๐ž๐ง๐จ๐ฎ๐ฌ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง (๐ˆ๐•๐ˆ๐†) ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐ž๐ซ๐ž:

Grifols
CSL Behring
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion Biopharma Inc.
Biotest AG
Shire Plc
China Biologic Products Holdings, Inc.
LFB S.A.
ADMA Biologics, Inc.

๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ (๐๐จ๐จ๐ค ๐๐จ๐ฐ ๐ฐ๐ข๐ญ๐ก ๐Ÿ๐ŸŽ% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ):

RNA Based Therapeutic Market https://www.alliedmarketresearch.com/rna-based-therapeutics-market

Epigenetics Market https://www.alliedmarketresearch.com/epigenetics-market

Exosome Diagnostic and Therapeutic Market https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exploring the Expanding Intravenous Immunoglobulin (IVIG) Market: Understanding the Growing Demand for Immunoglobulin Therapy in Treating Autoimmune and Neurological Disorders here

News-ID: 3018550 • Views: โ€ฆ

More Releases from Allied Market Research

Faucet Market Forecast 2035: Reaching USD 118.4 billion by 2035
Faucet Market Forecast 2035: Reaching USD 118.4 billion by 2035
According to a new report published by Allied Market Research, titled, "Faucet Market," The faucet market size was valued at $48.9 billion in 2023, and is estimated to reach $118.4 billion by 2035, growing at a CAGR of 7.6% from 2023 to 2035. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/2448 Faucet is a plumbing fixture used to control the flow of water in various settings such as kitchens,โ€ฆ
Vinyl Wallpaper Market Size Forecasted to Grow at 3.3% CAGR, Reaching USD 1.3 billion by 2031
Vinyl Wallpaper Market Size Forecasted to Grow at 3.3% CAGR, Reaching USD 1.3 bi โ€ฆ
The Vinyl Wallpaper Market Size was valued at $943.30 million in 2021, and is estimated to reach $1.3 billion by 2031, growing at a CAGR of 3.3% from 2022 to 2031. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/16970 Vinyl wallpaper consists of a carrier layer (recycled paper or non-woven wallpaper base) and a decorative layer made of polyvinyl chloride. A synthetic foam layer provides three-dimensional structures toโ€ฆ
Luxury Travel Market Set to Achieve a Valuation of US$ 2149.7 billion, Riding on a 7.4% CAGR by 2035
Luxury Travel Market Set to Achieve a Valuation of US$ 2149.7 billion, Riding on โ€ฆ
According to a new report published by Allied Market Research, titled, "Luxury Travel Market," The luxury travel market size was valued at $890.8 billion in 2023, and is estimated to reach $2149.7 billion by 2035, growing at a CAGR of 7.4% from 2024 to 2035. Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/1662 Luxury travel refers to travel experiences that offer exceptional comfort, exclusivity, and personalized services, typically catering toโ€ฆ
Men Personal Care Market to Grow at a CAGR of 8.6% and will Reach USD 276.9 billion by 2030
Men Personal Care Market to Grow at a CAGR of 8.6% and will Reach USD 276.9 bill โ€ฆ
According to a new report published by Allied Market Research, titled, "Men Personal Care Market by Type, Age Group, Price Point, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030," the men personal care market size is expected to reach $276.9 billion by 2030 at a CAGR of 8.6% from 2021 to 2030. Request The Sample PDF of This Report: @ https://www.alliedmarketresearch.com/request-sample/1701 Men personal care products are non-medicinalโ€ฆ

All 5 Releases


More Releases for IVIG

IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trendsโ€ฆ
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion. Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,โ€ฆ
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise โ€ฆ
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary researchโ€ฆ
04-10-2017 | Health & Medicine
TMR
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are โ€ฆ
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support marketโ€™s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across theโ€ฆ
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The term โ€œimmunoglobulinโ€ refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted fromโ€ฆ
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog โ€ฆ
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the companyโ€™s strong geographic penetration. Oligopoly in the market has led to intense competition among top players and has compelled companies to take course ofโ€ฆ